$NKTX 3 SEC Filings

Filed On	Filing
25 Jun 2025	Form 3: Rose Shawn Marshall, See Remarks No securities owned
31 Jul 2024	Form 3: Mahmood Nadir, President Holds 31,376 shares of Common Stock
14 Jun 2024	Form 3: Vratsanos George, Director No securities owned
05 Jul 2023	Form 3: Levin Alyssa, See Remarks No securities owned
10 Jan 2023	Form 3: Shook David, Chief Medical Officer Holds 22,977 shares of Common Stock
29 Mar 2022	Form 3: Thedinga Angela, Director No securities owned
31 Mar 2021	Form 3: Brandenberger Ralph, Sr. VP, Technical Operations
28 Oct 2020	Form 3: Hager Alicia J., Chief Legal Officer No securities owned
09 Jul 2020	Form 3: Behbahani Ali, Director No securities owned
09 Jul 2020	Form 3: Sonsini Peter W., 10% owner
09 Jul 2020	Form 3: Glaxosmithkline Plc, Director
09 Jul 2020	Form 3: Aynechi Tiba, Director No securities owned
09 Jul 2020	Form 3: Sandell Scott D, 10% owner
09 Jul 2020	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 2 others
09 Jul 2020	Form 3: Makower Joshua, 10% owner
09 Jul 2020	Form 3: Makhzoumi Mohamad, 10% owner
09 Jul 2020	Form 3: Florence Anthony A. Jr., 10% owner
09 Jul 2020	Form 3: Dybbs Michael, Director No securities owned
09 Jul 2020	Form 3: Baskett Forest, 10% owner
09 Jul 2020	Form 3: Scheiner Zachary, Director No securities owned

Comments